Season 4 | Episode 4

In this episode of Bell Curve, we are joined by Jon Charbonneau and Robert Miller to discuss how Ethereum's modular roadmap impacts the future of MEV. We explore L2 MEV design, decentralized sequencer models, cross-domain MEV, latency games, and Suave. Jon and Robert are two giga brains that understand the bleeding edge of modular MEV design!

- -

Timestamps:

(00:55) Intro: Pre-Interview

(02:39) How Ethereum’s Modular Roadmap Impacts MEV

(08:18) The Rollup Revolution: Consensus and Latency Games

(18:35) How Sequencers Work Today

(23:43) L2 MEV Models: Optimism and Arbitrum

(29:42) Why L2s Need PBS

(32:21) Decentralized Sequencer Designs

(44:45) Cross-Domain MEV and Atomicity

(53:46) Suave: The Mechanics, Order Flow Auctions & Roadmap

(57:07) “Rook Ad”

(59:09) Suave: The Mechanics, Order Flow Auctions & Roadmap

(1:27:50) Recap: Post-Interview

- -

Follow Jon: https://twitter.com/jon_charb

Follow Robert: https://twitter.com/bertcmiller

Follow Hasu: https://twitter.com/hasufl

Follow Mike: https://twitter.com/MikeIppolito_

Subscribe on YouTube: https://bit.ly/3R1D1D9

Subscribe on Apple: https://apple.co/3pQTfmD

Subscribe on Spotify: https://spoti.fi/3cpKZXH

- -

This episode is brought to you by Rook. Close to a billion dollars has already been taken out of users’ pockets through MEV. Rook built a solution that automatically drives this value back to where it belongs: with the users and applications that create it.

If you use on-chain products, tell your wallet, favorite app and go-to node provider to use Rook; if you're a developer, message us today to find out how to integrate Rook with your product. Follow Rook on Twitter and them a message at https://twitter.com/Rook.

- -

Resources:

Rollups Aren't Real by Jon

https://joncharbonneau.substack.com/p/rollups-arent-real

Hasu's Mevconomics talk

https://www.youtube.com/watch?v=6xS0xMzh9Tc&ab_channel=ETHGlobal

MEV Share

https://collective.flashbots.net/t/mev-share-programmably-private-orderflow-to-share-mev-with-users/1264

- -

Disclaimer: Nothing said on Bell Curve is a recommendation to buy or sell securities or tokens. This podcast is for informational purposes only, and any views expressed by anyone on the show are solely our opinions, not financial advice. Mike, Jason, Michael, Vance and our guests may hold positions in the companies, funds, or projects discussed.

Federal Funding Cuts Hit Cancer Research

KQED's Forum

Intro

The AI-powered Podcast Player